Is it Time to Hedge Your Stock Market Profits?
Since 2009 the stock market has achieved DOUBLE it's 30 year average return.
Double.
That's a big number, and one that's hard to sustain. I'm not calling for a market top but I am saying look both ways when you open your brokerage statement.
Believing the stock market will never go down is foolish, and expensive.
And unfortunately that is what most Americans think right now. Hedging simply means being smart with your profits. Ten years of vertical movement is not normal.
I'm not crying wolf, just saying to pay attention. A lot ready to hit the table in 2020.
Here's some insights into my first few years of trading and what it truly takes to be successful.
Pete
Billionaire Investor Issues Dire Economic Warning
Gundlach: The 2020s will see ‘real turmoil' as US debt woes come home to roost
In a recent discussion with Yahoo Finance, Gundlach compared the current expansion to the boom that took place nearly 100 years ago. But the next decade will be the opposite of the roaring 1920s, he said, as the debt bomb the U.S. is sitting on becomes untenable in the next economic downturn.
Analysts Love Nvidia Stock despite Trade War Fears
Nvidia (NVDA) stock has climbed only 1.2% since the company reported its Q3 of fiscal 2020 earnings on November 14. We note that the stock has been swinging up and down since its Q3 earnings release. It seems that the uncertain trade deal talks are hurting its stock.
Meanwhile, analysts still seem bullish on Nvidia stock despite the US-China trade war fears.
marketrealist.com/analysts-love-nvidia-stock
Investors are terrified of something a year from now and they’re placing bets to hedge themselves
Stock investors are hedging in a big way against something scary coming at them this time next year and it could be related to the outcome of the presidential election.
cnbc.com/2019/12/09/investors-are-terrified
Here’s the one Dow stock to buy now if you believe that what goes down must come up
marketwatch.com/dow-stock-to-buy-now
Potential takeover target in healthcare: analyst
Amid a flurry of deals in the healthcare sector Monday, Catalyst Funds' David Miller says Amarin is a possible acquisition target. He tells Reuters' Fred Katayama many insiders are buying shares of that biopharmaceutical maker.
